Bronchopulmonary pharmacokinetic (PK) profile of moxifloxacin in older adults undergoing diagnostic bronchoscopy Source: Eur Respir J 2002; 20: Suppl. 38, 421s Year: 2002
Clinical differences between elderly and nonelderly patients with COVID-19 Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021
Multiple-dose study of AMG 853 in healthy adults: Safety and pharmacokinetics Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010
Anthropometric determinants of lung function parameters in healthy Bulgarian children aged 7 to 18 years Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill Year: 2019
Clinical efficacy of moxifloxacin in severely ill patients with CAP Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009
Change in anti-asthmatic treatment over ten years in an international cohort of young and middle aged adults Source: Annual Congress 2004 - Asthma and allergy overtime: risks and management Year: 2004
Severity assessment in adults patients aged <50 years admitted with community acquired pneumonia Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Reference equations for lung function screening of healthy never smoking adults aged 18-80 years Source: Annual Congress 2008 - Lung function in respiratory disease Year: 2008
Single-dose, first-in-human study of AMG 317: safety and pharmacokinetics in healthy and asthmatic adults Source: Annual Congress 2008 - New treatments for asthma Year: 2008
Safety, pharmacokinetics and pharmacodynamics of BI 1323495 in healthy males Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020
Multiple-dose study of AMG 317 in adults with asthma: pharmacokinetics and safety Source: Annual Congress 2008 - New treatments for asthma Year: 2008
TB at patients older than 80 years Source: Eur Respir J 2005; 26: Suppl. 49, 420s Year: 2005
Prevalence and severity of asthma in the E3N study in 78 000 women, aged 50 years and over Source: Eur Respir J 2004; 24: Suppl. 48, 500s Year: 2004
Patterns of daily activity in COPD patients and aged matched controls Source: Eur Respir J 2001; 18: Suppl. 33, 222s Year: 2001
Population pharmacokinetics and pharmacodynamics of meropenem in elderly Chinese with lower respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Characteristics of pneumonians in children older than 3 years Source: Eur Respir J 2001; 18: Suppl. 33, 291s Year: 2001
Reference values for forced expiration parameters in Bulgarian children and adolescents aged 7 to 18 years Source: Eur Respir J 2005; 26: Suppl. 49, 612s Year: 2005
Long-term noninvasive ventilation: do patients aged over 75 years differ from younger adults ? Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020
Economic evaluation of eformoterol compared with salmeterol in children aged 6-17 years with symptomatic asthma in the UK: cost-effectiveness results of the FACT study Source: Eur Respir J 2001; 18: Suppl. 33, 122s Year: 2001
Reference equations for lung function parameters among a sardinian population aged over 80 years Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases Year: 2009